Melanoma escapes immune surveillance by manipulating immune checkpoints, such as programmed cell death protein 1 (PD-1) [19], programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated protein-4 (CTLA4) [20]. Here, CTLA4 is linked to melanoma.